Clinical Trials at SUNY Upstate Medical University
As of August 2026, 31 paid clinical trials are recruiting at SUNY Upstate Medical University, located at 750 E ADAMS ST, SYRACUSE, NY 13210-2342, phone (315) 464-5800 in Syracuse, New York. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Speech Sound Disorder and Alzheimer Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Syracuse
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
32 clinical trials at SUNY Upstate Medical University
·Clear filters·Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Strategy for Improving Stroke Treatment Response
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
A Study of Methylprednisolone in People Having Liver Surgery
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Vaginal Cuff Brachytherapy Fractionation Study
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
Evaluation and Optimization of Ultrasound and/or MRI Hardware and Software
Common conditions studied in Syracuse
- Acute Myeloid Leukemia (5 active studies)
- Speech Sound Disorder (5 active studies)
- Alzheimer Disease (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
Leading research sponsors in Syracuse
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Syracuse University
- VA Office of Research and Development
Frequently asked questions
How many paid clinical trials are currently recruiting in Syracuse?
There are approximately 177 recruiting clinical trials in Syracuse, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Syracuse pay participants?
Most recruiting trials in Syracuse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Syracuse?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Syracuse?
The most common conditions under active study in Syracuse include Acute Myeloid Leukemia (5), Speech Sound Disorder (5), Alzheimer Disease (4), Stage IV Lung Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Syracuse?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Syracuse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Syracuse?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Syracuse?
Recruiting research sites in Syracuse include State University of New York Upstate Medical University, SUNY Upstate Medical University, SUNY Upstate Medical Center-Community Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Syracuse right now?
The largest active categories in Syracuse are Cancer & tumors (77), Neurology & pain (13), Diabetes & metabolic (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of SUNY Upstate Medical University?
SUNY Upstate Medical University is located at 750 E ADAMS ST, SYRACUSE, NY 13210-2342. Use the Google Maps link in the intro above to get directions.
How do I contact SUNY Upstate Medical University?
You can reach SUNY Upstate Medical University by phone at (315) 464-5800. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.